TLCR Reading Tools
How to cite item
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced
EGFR
-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{79917}, author = {Zhang, D., Liu, X., Shen, F., Zhao, D., Shi, Y., Zhang, H., Liu, J., Gao, X., Chen, M., Zhao, J., Zhong, W., Gao, J., He, M., Liu, Y., Yang, X., Qin, J., Tang, Y., Mu, X., Gu, Y., Zhang, S., Chen, X., Pang, L., Meng, Q., Guo, Y., Zhang, Y., Li, W., Xing, P., Cheng, Y., Xin, T., Li, Q., Li, Y., Chen, J., Gao, F., Jin, B., Rossi, A., Adachi, H., Guerrera, F., Husain, H., Xu, Y., Wang, M.}, title = {Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced <em>EGFR</em>-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study}, journal = {Translational Lung Cancer Research}, volume = {12}, number = {11}, year = {2023}, url = {https://tlcr.amegroups.org/article/view/79917} }